HF 383: Relating to the controlled substance crystalline polymorph psilocybin. Vetoed 6-11-25

What it does

This bill relates to the controlled substance crystalline polymorph psilocybin.201(4)(s)).204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. The bill provides that upon the rescheduling of psilocybin, it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin.

Senate subcommittee · named March 3, 2025

• Sen. Mike Klimesh (R) · mike.klimesh@legis.iowa.gov
• Sen. Mike Pike (R) · mike.pike@legis.iowa.gov
• Sen. Zach Wahls (D) · zach.wahls@legis.iowa.gov

Lobbying · 4 for, 0 against

For: Compass Pathways; Dr. Tanja Garrison; Iowa Integrated Health Planning and Advisory Council; Mindspring Mental Health Alliance

In plain words

1. February 13, 2025Filed in the House
2. February 20, 2025Passed the House, 92–0
3. February 24, 2025Arrived in the Senate
4. March 3, 2025Senate subcommittee named: Klimesh, Pike and Wahls
5. March 20, 2025Subcommittee recommended passing it
6. April 3, 2025Approved by the Senate committee
7. April 16, 2025Passed the Senate, 47–0
8. May 19, 2025Sent to the Governor
9. June 11, 2025Vetoed by the Governor